Skip to content

CAL(Cell assisted lipo-transfer) in treating recurrent complex anal fistula

A Study to assess the Efficacy and Safety of the Cell Assisted Lipo-transfer in treating Recurrent Complex Peri-anal Fistula

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008334
Enrollment
20
Registered
2023-04-07
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : The stromal vascular fraction isolated from autologus fat of the patient and autologous fat will be mixed at a ratio of 1:9 The CAL mixture will be directly injected into and aroun

Sponsors

Hangun Hospital Bumcheon Campus
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a. Patients of complex perianal fistulas who is difficult to cure completely with conventional treatment. b. Patients with complex perianal fistula who has poor wound healing for more than 6 months due to repeated surgery c. Patients who are concerned about the possibility of fecal incontinence due to additional surgery. d. Refractory Crohn's fistula ? Adults aged 20 years or older who understand and voluntarily participate in this clinical study and can be followed for at least 1 year.

Exclusion criteria

Exclusion criteria: a. Elderly patients over 80 years of age who have difficulty managing after surgery, patients with chronic diseases who cannot stop taking medicine for 2 weeks. b. Patients with chronic anemia or malignant blood disease. c. Patients with reduced liver function due to liver disease. d. Patients with inflammatory diseases and chronic underlying conditions. (Intestinal perforation, ulcerative colitis, radiation proctitis, nephritis, obstructive respiratory disease, etc.) e. Patients unable to follow-up for more than 1 year or who do not wish to participate in the study

Design outcomes

Primary

MeasureTime frame
Wound healing: Disappearance of primary opening and secondary opening. ;Remission of inflammation

Secondary

MeasureTime frame
Recurrence

Countries

Korea, Republic of

Contacts

Public ContactJin Uk Choi

Hangun Hospital Bumcheon Campus

lordofkaze@naver.com+82-51-607-5300

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026